DE69324601D1 - Multifunktionelle neurotrophe faktoren - Google Patents

Multifunktionelle neurotrophe faktoren

Info

Publication number
DE69324601D1
DE69324601D1 DE69324601T DE69324601T DE69324601D1 DE 69324601 D1 DE69324601 D1 DE 69324601D1 DE 69324601 T DE69324601 T DE 69324601T DE 69324601 T DE69324601 T DE 69324601T DE 69324601 D1 DE69324601 D1 DE 69324601D1
Authority
DE
Germany
Prior art keywords
multifunctional
neurotrophic factors
neurotrophins
neurotrophic
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69324601T
Other languages
English (en)
Other versions
DE69324601T2 (de
Inventor
Carlos Ibanez
Hakan Persson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MCINTYRE KATHERINE R
Original Assignee
MCINTYRE KATHERINE R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MCINTYRE KATHERINE R filed Critical MCINTYRE KATHERINE R
Publication of DE69324601D1 publication Critical patent/DE69324601D1/de
Application granted granted Critical
Publication of DE69324601T2 publication Critical patent/DE69324601T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE69324601T 1992-11-20 1993-11-19 Multifunktionelle neurotrophe faktoren Expired - Lifetime DE69324601T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/979,630 US5488099A (en) 1992-03-06 1992-11-20 Multifunctional chimeric neurotrophic factors
PCT/US1993/011292 WO1994012539A1 (en) 1992-11-20 1993-11-19 Multifunctional neurotrophic factors

Publications (2)

Publication Number Publication Date
DE69324601D1 true DE69324601D1 (de) 1999-05-27
DE69324601T2 DE69324601T2 (de) 1999-12-02

Family

ID=25527026

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69324601T Expired - Lifetime DE69324601T2 (de) 1992-11-20 1993-11-19 Multifunktionelle neurotrophe faktoren

Country Status (10)

Country Link
US (2) US5488099A (de)
EP (1) EP0674660B1 (de)
JP (1) JPH08504405A (de)
AT (1) ATE179181T1 (de)
AU (1) AU677979B2 (de)
CA (1) CA2149862A1 (de)
DE (1) DE69324601T2 (de)
IL (1) IL107674A0 (de)
WO (1) WO1994012539A1 (de)
ZA (1) ZA938709B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573904B1 (de) * 1992-06-08 2001-09-26 Takeda Chemical Industries, Ltd. Therapeutisches Agens für Neutropenie
IL109280A0 (en) * 1993-04-15 1994-07-31 Regeneron Pharma Neurotrophins for treatment of depression
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors
US7144983B1 (en) 1997-02-03 2006-12-05 Genentech, Inc. Pantropic neurotrophic factors
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
HU222666B1 (hu) 1996-11-15 2003-09-29 Genentech, Inc. Eljárás neuorotrofinok tisztítására
US6663899B2 (en) * 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
CA2212315A1 (en) * 1997-08-05 1999-02-05 Mcgill University Pharmaceutical composition with neurotrophic-like biological activity
ATE406907T1 (de) * 1998-10-28 2008-09-15 Cornell Res Foundation Inc Methoden zur regulierung der angiogenese und vaskuläre integrität mittels trk rezeptor liganden bdnf, nt-3 und nt-4
ES2315842T3 (es) * 2004-01-19 2009-04-01 Nsgene A/S Celulas terapeuticas humanas que secretan factor de crecimiento nervioso.
EP2594295A1 (de) 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nervenimplantat basierend auf einem kompaktierten, zellhaltigen Biomaterial
CN115942951A (zh) * 2020-07-27 2023-04-07 人类细胞公司 Ngf变体,制备,组合物和治疗用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins

Also Published As

Publication number Publication date
EP0674660B1 (de) 1999-04-21
US5889173A (en) 1999-03-30
WO1994012539A1 (en) 1994-06-09
CA2149862A1 (en) 1994-06-09
JPH08504405A (ja) 1996-05-14
EP0674660A1 (de) 1995-10-04
AU5614894A (en) 1994-06-22
ATE179181T1 (de) 1999-05-15
ZA938709B (en) 1994-08-05
IL107674A0 (en) 1994-02-27
DE69324601T2 (de) 1999-12-02
AU677979B2 (en) 1997-05-15
US5488099A (en) 1996-01-30

Similar Documents

Publication Publication Date Title
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
ATE179181T1 (de) Multifunktionelle neurotrophe faktoren
ATE412052T1 (de) Synthetische polynukleotide
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
ID23374A (id) Halogenopirimidin
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
FR2711989B1 (fr) Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments.
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ATE153242T1 (de) Paramunitätsinducer auf der basis von kombinationen von pockenviruskomponenten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EA199800692A1 (ru) Изолируемые смеси из семян eugenia jambolana lamarck, способы их получения, способ получения оксамата натрия, лекарственные средства для профилактики и лечения диабета и применение указанных смесей, их компонентов и оксамата натрия для получения этих лекарственных средств
DE3752109D1 (de) Entzündungshemmende Mittel
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
MX9806041A (es) Proteina purificada sr-p70.
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
DK0614910T3 (da) Renset form af streptograminer, dens fremstilling og farmaceutiske præparater indeholdende denne form
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
NO885406D0 (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
DE69004808D1 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
BR9307363A (pt) Polipeptídeos bloqueadores dos canais de cálcio derivados de theraphosidae aphonopelma
NO982151L (no) Hemoregulatoriske forbindelser
DE3672892D1 (de) Herstellung von s-aryl-s-alkyl-dithiocarbonaten, arylthiolen und arylthioethern.
DE3576332D1 (de) Stickstoff-verbindungen, ihre herstellung und verwendung als ausgangsprodukte zur herstellung von decalinketonen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition